BACKGROUND AND PURPOSE: The CT angiography (CTA) spot sign predicts hematoma expansion and poor outcome in patients with primary intracerebral hemorrhage (ICH). The biological underpinnings of the spot sign remain poorly understood; it may be that the underlying vasculopathy influences its presence. Therefore, we conducted a study to identify genetic predictors of the spot sign. METHODS: In an ongoing prospective cohort study, we analyzed 371 patients with CTA and genetic data available. CTAs were reviewed for the spot sign by 2 experienced readers, blinded to clinical data, according to validated criteria. Analyses were stratified by ICH location. RESULTS: In multivariate analysis, patients on warfarin were more likely to have a spot sign regardless of ICH location (OR, 3.85; 95% CI, 1.33-11.13 in deep ICH and OR, 2.86; 95% CI, 1.33-6.13 in lobar ICH). Apolipoprotein E ε2, but not ε4, was associated with the presence of a spot sign in lobar ICH (OR, 2.09; 95% CI, 1.05-4.19). There was no effect for ε2 or ε4 in deep ICH. CONCLUSIONS: Patients with ICH on warfarin are more likely to present with a spot sign regardless of ICH location. Among patients with lobar ICH, those who possess the apolipoprotein E ε2 allele are more likely to have a spot sign. Given the established relationship between apolipoprotein E ε2 and vasculopathic changes in cerebral amyloid angiopathy, our findings suggest that both hemostatic factors and vessel pathology influence spot sign presence.
BACKGROUND AND PURPOSE: The CT angiography (CTA) spot sign predicts hematoma expansion and poor outcome in patients with primary intracerebral hemorrhage (ICH). The biological underpinnings of the spot sign remain poorly understood; it may be that the underlying vasculopathy influences its presence. Therefore, we conducted a study to identify genetic predictors of the spot sign. METHODS: In an ongoing prospective cohort study, we analyzed 371 patients with CTA and genetic data available. CTAs were reviewed for the spot sign by 2 experienced readers, blinded to clinical data, according to validated criteria. Analyses were stratified by ICH location. RESULTS: In multivariate analysis, patients on warfarin were more likely to have a spot sign regardless of ICH location (OR, 3.85; 95% CI, 1.33-11.13 in deep ICH and OR, 2.86; 95% CI, 1.33-6.13 in lobar ICH). Apolipoprotein E ε2, but not ε4, was associated with the presence of a spot sign in lobar ICH (OR, 2.09; 95% CI, 1.05-4.19). There was no effect for ε2 or ε4 in deep ICH. CONCLUSIONS:Patients with ICH on warfarin are more likely to present with a spot sign regardless of ICH location. Among patients with lobar ICH, those who possess the apolipoprotein E ε2 allele are more likely to have a spot sign. Given the established relationship between apolipoprotein E ε2 and vasculopathic changes in cerebral amyloid angiopathy, our findings suggest that both hemostatic factors and vessel pathology influence spot sign presence.
Authors: H Bart Brouwers; Alessandro Biffi; Alison M Ayres; Kristin Schwab; Lynelle Cortellini; Javier M Romero; Natalia S Rost; Anand Viswanathan; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein Journal: Stroke Date: 2012-04-24 Impact factor: 7.914
Authors: S M Greenberg; J P Vonsattel; A Z Segal; R I Chiu; A E Clatworthy; A Liao; B T Hyman; G W Rebeck Journal: Neurology Date: 1998-04 Impact factor: 9.910
Authors: Alessandro Biffi; Akshata Sonni; Christopher D Anderson; Brett Kissela; Jeremiasz M Jagiella; Helena Schmidt; Jordi Jimenez-Conde; Björn M Hansen; Israel Fernandez-Cadenas; Lynelle Cortellini; Alison Ayres; Kristin Schwab; Karol Juchniewicz; Andrzej Urbanik; Natalia S Rost; Anand Viswanathan; Thomas Seifert-Held; Eva-Maria Stoegerer; Marta Tomás; Raquel Rabionet; Xavier Estivill; Devin L Brown; Scott L Silliman; Magdy Selim; Bradford B Worrall; James F Meschia; Joan Montaner; Arne Lindgren; Jaume Roquer; Reinhold Schmidt; Steven M Greenberg; Agnieszka Slowik; Joseph P Broderick; Daniel Woo; Jonathan Rosand Journal: Ann Neurol Date: 2010-12 Impact factor: 10.422
Authors: Shoichiro Sato; Hisatomi Arima; Yoichiro Hirakawa; Emma Heeley; Candice Delcourt; Ronny Beer; Yuechun Li; Jingfen Zhang; Eric Jüettler; Jiguang Wang; Pablo M Lavados; Thompson Robinson; Richard I Lindley; John Chalmers; Craig S Anderson Journal: Neurology Date: 2014-11-05 Impact factor: 9.910
Authors: H Bart Brouwers; Miriam R Raffeld; Koen M van Nieuwenhuizen; Guido J Falcone; Alison M Ayres; Kristen A McNamara; Kristin Schwab; Javier M Romero; Birgitta K Velthuis; Anand Viswanathan; Steven M Greenberg; Christopher S Ogilvy; Albert van der Zwan; Gabriel J E Rinkel; Joshua N Goldstein; Catharina J M Klijn; Jonathan Rosand Journal: Neurology Date: 2014-08-06 Impact factor: 9.910
Authors: Andreas Charidimou; Gregoire Boulouis; Kellen Haley; Eitan Auriel; Ellis S van Etten; Panagiotis Fotiadis; Yael Reijmer; Alison Ayres; Anastasia Vashkevich; Zora Y Dipucchio; Kristin M Schwab; Sergi Martinez-Ramirez; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg; M Edip Gurol Journal: Neurology Date: 2016-01-08 Impact factor: 9.910
Authors: Farid Radmanesh; Guido J Falcone; Christopher D Anderson; Thomas W K Battey; Alison M Ayres; Anastasia Vashkevich; Kristen A McNamara; Kristin Schwab; Javier M Romero; Anand Viswanathan; Steven M Greenberg; Joshua N Goldstein; Jonathan Rosand; H Bart Brouwers Journal: Stroke Date: 2014-05-13 Impact factor: 7.914
Authors: William J Devan; Guido J Falcone; Christopher D Anderson; Jeremiasz M Jagiella; Helena Schmidt; Björn M Hansen; Jordi Jimenez-Conde; Eva Giralt-Steinhauer; Elisa Cuadrado-Godia; Carolina Soriano; Alison M Ayres; Kristin Schwab; Sylvia Baedorf Kassis; Valerie Valant; Joanna Pera; Andrzej Urbanik; Anand Viswanathan; Natalia S Rost; Joshua N Goldstein; Paul Freudenberger; Eva-Maria Stögerer; Bo Norrving; David L Tirschwell; Magdy Selim; Devin L Brown; Scott L Silliman; Bradford B Worrall; James F Meschia; Chelsea S Kidwell; Joan Montaner; Israel Fernandez-Cadenas; Pilar Delgado; Steven M Greenberg; Jaume Roquer; Arne Lindgren; Agnieszka Slowik; Reinhold Schmidt; Daniel Woo; Jonathan Rosand; Alessandro Biffi Journal: Stroke Date: 2013-04-04 Impact factor: 7.914
Authors: Lei Yu; Patricia A Boyle; Sukriti Nag; Sue Leurgans; Aron S Buchman; Robert S Wilson; Zoe Arvanitakis; Jose M Farfel; Philip L De Jager; David A Bennett; Julie A Schneider Journal: Neurobiol Aging Date: 2015-08-15 Impact factor: 4.673